TY - JOUR
T1 - Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates
AU - Kawamura, Masafumi
AU - Izumi, Yotaro
AU - Tsukada, Norimasa
AU - Asakura, Keisuke
AU - Sugiura, Hiroaki
AU - Yashiro, Hideki
AU - Nakano, Keiko
AU - Nakatsuka, Seishi
AU - Kuribayashi, Sachio
AU - Kobayashi, Koichi
PY - 2006/5
Y1 - 2006/5
N2 - Objective: Cryoablation of pulmonary metastases might be a useful therapy for nonsurgical candidates. Methods: The procedure was performed after achievement of local anesthesia for 35 tumors in 20 patients (12 male and 8 female patients; mean age, 57 years). The primary end point was the safety and feasibility of cryoablation, and the secondary end point was tumor control assessed by follow-up dynamic computed tomographic scanning performed every 3 months. Results: Of the 22 sessions of cryoablation, pneumothorax occurred in 11, hemoptysis occurred in 8, and there was 1 case of phrenic nerve palsy. The mean hospital stay was 2.6 days. There was local recurrence of 7 (20%) tumors in 7 (35%) patients during a 9- to 28-month (median, 21 months) follow-up period. One-year survival according to the Kaplan-Meier method was 89.4%. Conclusion: Percutaneous cryoablation therapy for metastatic lung tumors is feasible and minimally invasive, with satisfactory local control.
AB - Objective: Cryoablation of pulmonary metastases might be a useful therapy for nonsurgical candidates. Methods: The procedure was performed after achievement of local anesthesia for 35 tumors in 20 patients (12 male and 8 female patients; mean age, 57 years). The primary end point was the safety and feasibility of cryoablation, and the secondary end point was tumor control assessed by follow-up dynamic computed tomographic scanning performed every 3 months. Results: Of the 22 sessions of cryoablation, pneumothorax occurred in 11, hemoptysis occurred in 8, and there was 1 case of phrenic nerve palsy. The mean hospital stay was 2.6 days. There was local recurrence of 7 (20%) tumors in 7 (35%) patients during a 9- to 28-month (median, 21 months) follow-up period. One-year survival according to the Kaplan-Meier method was 89.4%. Conclusion: Percutaneous cryoablation therapy for metastatic lung tumors is feasible and minimally invasive, with satisfactory local control.
UR - http://www.scopus.com/inward/record.url?scp=33646186541&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646186541&partnerID=8YFLogxK
U2 - 10.1016/j.jtcvs.2005.12.051
DO - 10.1016/j.jtcvs.2005.12.051
M3 - Article
C2 - 16678583
AN - SCOPUS:33646186541
SN - 0022-5223
VL - 131
SP - 1007
EP - 1013
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 5
ER -